| First Author | Ying J | Year | 2020 |
| Journal | JCI Insight | Volume | 5 |
| Issue | 3 | PubMed ID | 32051335 |
| Mgi Jnum | J:301912 | Mgi Id | MGI:6505359 |
| Doi | 10.1172/jci.insight.131816 | Citation | Ying J, et al. (2020) Dnmt3b ablation impairs fracture repair through upregulation of Notch pathway. JCI Insight 5(3) |
| abstractText | We previously established that DNA methyltransferase 3b (Dnmt3b) is the sole Dnmt responsive to fracture repair and that Dnmt3b expression is induced in progenitor cells during fracture repair. In the current study, we confirmed that Dnmt3b ablation in mesenchymal progenitor cells (MPCs) resulted in impaired endochondral ossification, delayed fracture repair, and reduced mechanical strength of the newly formed bone in Prx1-Cre;Dnmt3bf/f (Dnmt3bPrx1) mice. Mechanistically, deletion of Dnmt3b in MPCs led to reduced chondrogenic and osteogenic differentiation in vitro. We further identified Rbpjkappa as a downstream target of Dnmt3b in MPCs. In fact, we located 2 Dnmt3b binding sites in the murine proximal Rbpjkappa promoter and gene body and confirmed Dnmt3b interaction with the 2 binding sites by ChIP assays. Luciferase assays showed functional utilization of the Dnmt3b binding sites in murine C3H10T1/2 cells. Importantly, we showed that the MPC differentiation defect observed in Dnmt3b deficiency cells was due to the upregulation of Rbpjkappa, evident by restored MPC differentiation upon Rbpjkappa inhibition. Consistent with in vitro findings, Rbpjkappa blockage via dual antiplatelet therapy reversed the differentiation defect and accelerated fracture repair in Dnmt3bPrx1 mice. Collectively, our data suggest that Dnmt3b suppresses Notch signaling during MPC differentiation and is necessary for normal fracture repair. |
